Related Experiment Videos
Intravitreal bevacizumab in a patient with a macular star in malignant hypertension
Ilaria Zucchiatti1, Pierluigi Iacono, Maurizio Battaglia Parodi
1Department of Ophthalmology, University Vita-Salute, Scientific Institute San Raffaele, Milan, Italy.
Purpose:
To report a case of retinopathy secondary to malignant hypertension showing a macular star, which responded favorably to a single intravitreal injection of bevacizumab (IVB).
Methods:
A 46-year-old man with malignant hypertension showing incomplete macular star in his right eye with best-corrected visual acuity (BCVA) of 20/32 underwent IVB.
Results:
Subsequent examinations revealed a progressive resolution of the macular star with functional recovery over the follow-up. In particular, at the 9-month examination BCVA was 20/20, fundus biomicroscopy disclosed resolution of the macular star, and the retinal sensitivity improved remarkably.
Conclusions:
Intravitreal injection of bevacizumab can be a useful approach to treat the exudative manifestations of malignant hypertension.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Glaucoma: Overview
Diabetic Retinopathy